What is the Historical Analysis of the Contraceptives Market Size?
The contraceptives market has seen considerable growth due to a variety of factors.
• The market size for contraceptives has seen significant growth in the past few years. The market is projected to expand from $27.92 billion in 2024 to $30.05 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%.
The escalation in the past duration is credited to the launch of the birth control pill, improved consciousness and education on contraception, revisions in laws and societal norms that endorse reproductive rights, worldwide initiatives to control population, and an escalation in the usage of generic and affordable drugs and devices.
What is the Forecasted Growth of the Contraceptives Market Size?
The contraceptives market is expected to maintain its strong growth trajectory in upcoming years.
• The contraceptives market is projected to experience robust growth in the upcoming years, surging to a value of $40.89 billion in 2029 with a CAGR of 8.0%.
This expansion during the forecast period can be ascribed to the increased emphasis on male contraceptives, improved contraceptive access in developing nations, the incorporation of digital health technologies in contraceptive use, the rising need for long-acting reversible contraceptives (LARCS), and the expanded accessibility to over-the-counter drugs online. The forecast period will also be marked by dominant trends like the technological progression in contraceptive methods, a shift towards non-hormonal and natural contraceptive methods, wider over-the-counter access to some contraceptives, the focus on user-friendly and discreet contraceptive options, and the inclusion of telemedicine in contraceptive consultations and prescriptions.
What Key Factors and Trends are Driving the Growth of the Contraceptives Market?
An upswing of sexually transmitted diseases or STDs is escalating the need for contraceptives. Sexually transmitted infections are propagated from one individual to another via sexual activity. The most common transfer points are anal, oral, and vaginal sex, but they can also be spread through other forms of close physical contact. Contraceptives are utilized in order to control the spread of diseases like herpes and HPV, predominantly passed through skin-on-skin contact. For instance, the Minnesota Department of Health, a public health agency in the US, reported in May 2023 that primary and secondary syphilis cases increased by 19% in 2022, escalating from 564 in 2021 to 676 in 2022. Congenital syphilis cases in newborns documented in 2022 were 20, a 42% surge from the 14 cases reported in 2021. Hence, the upsurge in sexually transmitted diseases is predicted to augment the demand for contraceptives over the forecast period.
What are the Market Segments in the Contraceptives Market?
The contraceptives market covered in this report is segmented –
1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices
2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years
3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels
Subsegments:
1) By Oral Contraceptive Pills: Combination Pills, Progestin-Only Pills
2) By Topical Contraceptives: Transdermal Patches, Gel Applications
3) By Injectables: Hormonal Injectables, Non-Hormonal Injectables
4) By Diaphragms: Silicone Diaphragms, Latex Diaphragms
5) By Vaginal Rings: Hormonal Rings, Non-Hormonal Rings
6) By Condoms: Male Condoms, Female Condoms
7) By Contraceptive Sponges: Non-Hormonal Sponges, Hormonal Sponges
8) By Subdermal Implants: Hormonal Implants, Non-Hormonal Implants
9) By Intra-Uterine Devices (IUDs): Hormonal IUDs, Copper IUDs
Pre-Book The Contraceptives Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends are Shaping the Contraceptives Market?
Major firms in the contraceptive market are working to create cutting-edge products like the Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptives. These innovations strive to boost user-friendliness, efficiency and provide long-term options for birth control. The aim is to lessen the requirement for frequent dosing, enhance accessibility and limit adverse reactions. They aim to provide more dependable and unnoticeable contraceptive options for people seeking improved management of reproductive health. For example, in October 2023, the Health and Family Welfare Ministry, a government organization in India, introduced two new methods - Single Rod Subdermal Implant and Subcutaneous Injectable Contraceptive with the aim of improving family planning services. These methods are included in the National Family Planning Programme and strive to better maternal and child health outcomes. The deployment of these contraceptives aims to lower the rates of maternal and infant disease and death by offering more family planning options. This initiative is representative of wider plans to improve reproductive health services in Karnataka, ensuring women have access to safe and effective forms of contraception.
Who Are the Key Players in the Contraceptives Market?
Major companies operating in the contraceptives market include:
• Merck & Co. Inc.
• Bayer AG
• Church & Dwight Co. Inc.
• Cipla Inc.
• Reckitt Benckiser Group plc
• Agile Therapeutics Inc.
• Allergan Ltd.
• Aurobindo Pharma Limited
• Famy Care Ltd.
• Glenmark Pharmaceuticals Limited
• HLL Lifecare Limited
• Johnson & Johnson
• Laboratoire HRA Pharma SAS
• Lupin Limited
• Mankind Pharma Ltd.
• Mayer Laboratories Inc.
• Medisafe Distribution Inc.
• Mithra Pharmaceuticals SA
• Mylan NV
• Okamoto Industries Inc.
• Pfizer Inc.
• Pregna International Ltd.
• Syncom Pharmaceuticals
• Teva Pharmaceutical Industries Ltd.
• The Population Council
• Veru Inc.
• Zydus Cadila
• Shanghai Dahua Pharmaceutical Co. Ltd.
• Sichuan Kangdi Pharmaceutical Co. Ltd.
• Beijing Zhengyuan Pharmaceutical Co. Ltd.
• Zhejiang Huahai Pharmaceutical Co. Ltd.
• Chongqing Pharmaceutical Group Co. Ltd.
What are the Regional Insights into the Contraceptives Market?
North America was the largest region in the contraceptives market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
